Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Selig

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 10, 2024
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for cliniciansKuldip D Dave, Björn Oskarsson, Jill Yersak, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2022
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshopJose M Garcia, Richard F Dunne, Kristen Santiago, et al.
Journal for Immunotherapy of Cancer|May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatmentHoward L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 10, 2024
Contributions of neurologists to diagnostic timelines of ALS and thinkALS as an early referral instrument for cliniciansKuldip D Dave, Björn Oskarsson, Jill Yersak, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 26, 2022
Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshopJose M Garcia, Richard F Dunne, Kristen Santiago, et al.
Journal for Immunotherapy of Cancer|May 19, 2019
The promise of Immuno-oncology: implications for defining the value of cancer treatmentHoward L Kaufman, Michael B Atkins, Prasun Subedi, et al.
Pageof 2